Skip to main content
. 2025 Mar 30;14(7):2376. doi: 10.3390/jcm14072376
AD Atopic dermatitis
AZA Azathioprine
BoNT-A Botulinum toxin A
BSA Body Surface Area
COC Combined oral contraceptives
CsA Cyclosporine
DLQI Dermatology Life Quality
EC European Committee
EMA European Medicines Agencies
FDA Food and Drug Administration
GCS Glucocorticosteroids
GM-CSF Granulocyte-macrophage colony-stimulating factor
HLA Human leukocyte antigen
i.m. Intramuscularis
i.v. Intravenosa
IFN Interferone
IL Interleukin
IPL Intense pulsed light
JAK Januse
MMF Mycophenolate mofetil
MTX Methotrexate
PASI Psoriasis Area and Severity Index
RCT Randomized Clinical Trials
sc. Subcutanea
SCORAD Scoring Atopic Dermatitis
SmPC Summary of Product Characteristics
TCI Topical Calcineurin Inhibitors
TNF Tumor necrosis factor